Mettler Toledo International Inc 's ROA from the third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Mettler Toledo International Inc 's ROA in the third quarter of 2026?
Mettler toledo International Inc achieved a return on average assets (ROA) of 25.22 % in its third quarter of 2026, this is above MTD's average return on assets of 18.21%.
Mettler Toledo International Inc s assets during the 12 months ending in the third quarter of 2026 are valued at $3 billion

ROA has improved compared to 24.8% in the second quarter of 2026, due to net income growth.

However, within the Healthcare sector 39 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Sep 30 2026 quarter, so far to 163, from total ROA ranking in the second quarter of 2026 at 186.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Sep 30 2026) III. Quarter	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter
Y / Y Total Assets Change	5.99 %	9.11 %	14.62 %	11.78 %	5.99 %
Y / Y Net Income Change	13.09 %	15.1 %	3.59 %	13.26 %	2.83 %
Net Income (TTM) in million	934	906	875	869	836
Return On Assets (TTM)	25.22 %	24.8 %	24.48 %	25.14 %	24.89 %
MTD's Total Ranking	# 163	# 186	# 180	# 170	# 156
Total Assets (TTM) in million	3,695	3,671	3,669	3,780	3,487
Seq. Total Assets Change	0.67 %	0.06 %	-2.93 %	8.4 %	3.63 %
Seq. Net Income Change	5.61 %	37.44 %	-40.7 %	31.39 %	7.48 %

MTD's 5 Years Annual ROA >> Back to MTD Management Effectiveness >> Compare MTD ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 0
Sector	# 40
Overall	# 154

Return On Assets Statistics
High	Average	Low
26.37 %	18.21 %	10.59 %
(Dec 31 2024)		(July 26. 2008)

Financial Statements
Mettler Toledo International Inc 's Assets	$ 3,695 million	MTD's Balance sheet
Mettler Toledo International Inc 's Income	$ 246 million	Quarterly MTD's Income Statement
MTD's Income by Division		See MTD's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021
Y / Y Total Assets Change	15.76 %	-3.54 %	-4.06 %	5.39 %	16.85 %
Total Assets in million	3,713	3,207	3,325	3,466	3,289
Y / Y Net Income Change	0.7 %	9.43 %	-9.6 %	13.46 %	27.58 %
Net Income in million	869	863	789	873	769
Annual Return On Assets	23.41 %	26.91 %	23.72 %	25.17 %	23.38 %

MTD's 5 Years Annual ROA >> Back to MTD Management Effectiveness >> Compare MTD ROA to its Competitors

Comment on MTD's ROA in the fiscal year ending 2025

In the fiscal year 2025 ROA deteriorated to 23.41 %, despite annual net income growth of 0.7 % to $869.19 million, from $863.14 million a year ago, as MTD's assets increase to $3,712.65 million, by 0.7 %.

More Return On Assets Ratios
MTD's' Return on Assets at Yahoo Finance
Laboratory Analytical Instruments Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
MTD's Roa Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for MTD's Competitors
Subscribers only: Roa for Mettler Toledo International Inc 's Suppliers
Subscribers only: Return On Assets for MTD's Customers

You may also want to know
MTD's Roi	MTD's Inventory Turnover Ratio	MTD's Growth Rates	MTD's Dividend Comparisons
	MTD's Profitability Ratios	MTD's Asset Turnover Ratio	MTD's Dividend Growth
MTD's Roe	MTD's Valuation Ratios	MTD's Financial Strength Ratios	MTD's Dividend Payout Ratio

Companies with similar Return On Assets at Sep 30 2026, within Healthcare Sector	ROA
Exelixis Inc	63.88 %
Rigel Pharmaceuticals Inc	59.56 %
Alnylam Pharmaceuticals Inc	46.08 %
Ironwood Pharmaceuticals inc	42.53 %
Aurinia Pharmaceuticals Inc	40.63 %
Nurix Therapeutics Inc	38.61 %
Indivior Pharmaceuticals Inc	36.35 %
Rallybio Corporation	34.55 %
Idexx Laboratories Inc	34.05 %
Zevra Therapeutics Inc	26.33 %
Caredx Inc	25.74 %
Medpace Holdings Inc	24.47 %
Acadia Pharmaceuticals Inc	21.60 %
Standard Biotools Inc	21.56 %
Eli Lilly And Company	21.24 %
Iradimed Corporation	20.89 %
Resmed Inc	18.67 %
Alector Inc	18.37 %
Corcept Therapeutics Inc	18.09 %
Chemed Corporation	17.73 %
Halozyme Therapeutics Inc	17.26 %
Pro dex Inc	16.75 %
Denali Therapeutics Inc	16.42 %
Krystal Biotech Inc	15.48 %
West Pharmaceutical Services Inc	15.47 %
Dexcom Inc	15.47 %
Intuitive Surgical Inc	14.71 %
Vertex Pharmaceuticals Inc	14.16 %
Neurocrine Biosciences Inc	13.69 %
Illumina Inc	13.43 %

Date modified: 2026-11-09T18:44:26+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.